Editorial

DOI: 10.4244/EIJ-E-25-00003

Do we need to be fully complete in multivessel acute myocardial infarction?

Pieter C. Smits1, MD, PhD; Valeria Paradies2, MD, MSc

In 2012, the European Society of Cardiology (ESC) Guidelines for the management of acute ST-segment elevation myocardial infarction (STEMI) stated that primary percutaneous coronary intervention (PCI) should be limited to the culprit vessel with the exception of cardiogenic shock (Class IIa, Level of Evidence B recommendation) and, in case of multivessel disease with non-culprit lesions suitable for revascularisation stress testing, or imaging for ischaemia or viability is indicated (Class I, Level of Evidence A recommendation).

In the past 10 years, these recommendations have shifted almost in the opposite direction. It started with the PRAMI study, the first randomised controlled trial (RCT) that challenged the concept that primary PCI should be limited to the culprit vessel only and disregarded the need for additional ischaemia testing for non-culprit lesions1. PRAMI randomised patients between culprit-only treatment and angiography-guided complete revascularisation by PCI (preventive PCI) and showed that a preventive PCI strategy significantly reduced the composite endpoint of cardiac death, recurrent non-fatal myocardial infarction and refractory angina. Even without the “soft” endpoint of refractory angina, the study was positive for the composite of the...

Sign in to read
the full article

Forgot your password?
No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Volume 21 Number 4
Feb 17, 2025
Volume 21 Number 4
View full issue


Key metrics

Suggested by Cory

10.4244/EIJV10STA9 Aug 19, 2014
Multivessel PCI in STEMI: ready to be the recommended strategy?
Cuisset T and Noc M
free

State-of-the-Art Review

10.4244/EIJ-D-20-00957 Jun 25, 2021
Completeness of revascularisation in acute coronary syndrome patients with multivessel disease
Paradies V et al
free

10.4244/EIJV13I16A304 Mar 20, 2018
STEMI – are we there yet?
Gershlick A
free

10.4244/EIJV16I3A34 Jun 25, 2020
Complete revascularisation in the STEMI patient: is it worth the effort?
Gershlick A and Banning AS
free

Letter to the editor

10.4244/EIJ-D-25-00325 Jun 16, 2025
Reply: Completeness or complexity? A nuanced reflection on multivessel revascularisation
Laudani C et al
free

Debate

10.4244/EIJ-E-23-00045 Feb 5, 2024
Complete revascularisation should be immediate in STEMI: pros and cons
Kastrati A et al
free
Trending articles
172.05

Focus article

10.4244/EIJY19M08_01 Jan 17, 2020
EHRA/EAPCI expert consensus statement on catheter-based left atrial appendage occlusion – an update
Glikson M et al
free
79.55

State-of-the-Art

10.4244/EIJ-D-24-00066 Apr 21, 2025
Management of complications after valvular interventions
Bansal A et al
free
42

Original Research

10.4244/EIJ-D-25-00331 May 21, 2025
One-month dual antiplatelet therapy followed by prasugrel monotherapy at a reduced dose: the 4D-ACS randomised trial
Jang Y et al
open access
X

The Official Journal of EuroPCR and the European Association of Percutaneous Cardiovascular Interventions (EAPCI)

EuroPCR EAPCI
PCR ESC
Impact factor: 9.5
2024 Journal Citation Reports®
Science Edition (Clarivate Analytics, 2025)
Online ISSN 1969-6213 - Print ISSN 1774-024X
© 2005-2025 Europa Group - All rights reserved